BioCryst Pharma News, BioCryst Pharma Quote, BCRX Quote

BioCryst Pharma (NQ:BCRX) Delayed: 6.95 -0.16 (2.25%)

Prev. Close

$7.11

Open

$7.05

52 Wk High

$10.98

52 Wk Low

$1.63

Day High

$7.19

Day Low

$6.95

P/E

N/A

EPS

$-0.68

Volume

491,662

Friends, Peers and Foes (?): NDSN, AA, MASI, SHOP MRK (more...)

Sep 18, 2023 07:02 AM BioCryst Pharma (BCRX) Announces INESSS Recommends Public Reimbursement for ORLADEYO
Sep 18, 2023 07:00 AM INESSS Recommends Public Reimbursement for BioCryst’s ORLADEYO® (berotralstat) for the Prevention of Attacks for Hereditary Angioedema Patients in Québec
Sep 18, 2023 05:06 AM RBC Capital Upgrades BioCryst Pharma (BCRX) to Outperform, 'Doc Survey Suggesting Good Orladeyo Metrics'
Sep 5, 2023 04:44 PM Form 4 BIOCRYST PHARMACEUTICALS For: Aug 31 Filed by: MILANO VINCENT
Sep 5, 2023 04:42 PM Form 4 BIOCRYST PHARMACEUTICALS For: Aug 31 Filed by: HEGGIE THERESA
Sep 5, 2023 07:00 AM BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 23, 2023 04:01 PM BioCryst to Present at Upcoming Investor Conferences
Aug 7, 2023 04:56 PM Form 10-Q BIOCRYST PHARMACEUTICALS For: Jun 30
Aug 4, 2023 04:01 PM BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 4, 2023 07:12 AM Jefferies Upgrades BioCryst Pharma (BCRX) to Buy

Entities mentioned with BCRX